LLY

Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs · BCBA:LLY

41,800.00 ARS1,460.00 +3.62%

Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs (BCBA:LLY) last traded at 41,800.00 ARS, up 3.62% on the day. Over the past year the stock is up 89.40%. Its 52-week range is 22,670.00 to 42,600.00. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open41,820.00

Day range41,740.00 – 42,600.00

52-week range22,670.00 – 42,600.00

Volume33.01 K

Average volume (10 days)24.34 K

Market cap (USD)1.33 T

P/E53.45

EPS (TTM) (USD)0.5123

Dividend yield0.27%

Beta (1 year)−0.006840

Revenue (TTM) (USD)81.72 B

Employees50.00 K

Performance

+9.31%1 week

+21.58%1 month

+29.41%3 months

+75.70%6 months

+42.18%Year to date

+89.40%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Cathie Wood's weekly recap: loads TER, AVAV after strong results; books gain in AMD, TSM, LLYSeeking Alpha · 02 Nov 2026
Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Elon Musk Says Eli Lilly Has ‘Some Banger Drugs Coming Out’ After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech SkepticismBenzinga · 31 Oct 2026
Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Stocktwits · 31 Oct 2026
Eli Lilly Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
UBS maintains Eli Lilly at Buy, raises price target to $1625 from $1425TradingView · 31 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.